Skip to content
Roboearth – Lifestyle
Author:
Labcorp
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
June 22, 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
May 29, 2026